reductions

Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025

- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data from Phase…

1 week ago

GMS Reports Fourth Quarter and Fiscal Year 2025 Results

Resilient Pricing Despite Challenging and Uncertain End Market Conditions; Additional Structural Cost Reductions RealizedTUCKER, Ga.--(BUSINESS WIRE)--GMS Inc. (NYSE: GMS), a…

1 month ago

Dupixent (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall…

1 month ago